Skeletal muscle involvement in systemic amyloidosis is often overlooked
Neuropathology and Applied Neurobiology · 2024
DOI: 10.1111/nan.12996 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropathology and Applied Neurobiology, 2024. Verfasst von Jingwen Xu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Neuromuscular and Neurodegenerative Diseases, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Muscle, Skeletal, Muscular Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Nature Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Aim
Systemic amyloidosis is a condition in which misfolded amyloid fibrils are deposited within tissues. Amyloid myopathy is a rare manifestation of systemic amyloidosis. However, whether skeletal muscle involvement is underestimated and whether such deposition guarantees clinical and pathological myopathic features remain to be investigated.
Methods
We retrospectively reviewed patients with systemic amyloidosis, in whom skeletal muscle biopsies were performed at our centre between January 2018 and June 2023. In total, 28 patients with suspected systemic amyloidosis were included. Among these, 21 presented with cardiomyopathy but lacked myopathic symptoms. The clinical and pathological data of these patients were further analysed. The amyloid type was confirmed by immunohistochemistry.
Results
Twenty‐eight patients with suspected systemic amyloidosis underwent muscle biopsy. Amyloid deposition in the skeletal muscle was confirmed in 24 patients, including 22 with light‐chain amyloidosis (AL) and two with transthyretin amyloidosis (ATTR). Among the 24 patients, seven presented with muscle weakness and decreased muscle strength (Group 1, symptomatic myopathy), whereas the remaining 17 exhibited normal muscle strength (Group 2, asymptomatic myopathy). Group 1 included four patients with AL‐λ, one with AL‐κ and two with ATTR. Group 2 included 15 patients with AL‐λ and two patients with AL‐κ. In Group 1, six patients exhibited neuropathy, whereas only one patient in Group 2 presented with subclinical neuropathy on nerve conduction studies. Amyloid deposition in the interstitium was the most obvious change, observed in all 24 patients. Neuropathic changes, including denervation atrophy and muscle fibre grouping, were also common. Except for type 2 fibre atrophy, the other myopathic changes were mild and nonspecific. No sarcolemmal disruption was observed. Immunohistochemical analysis revealed marked positivity for MAC and MHC1 expression in the regions with amyloid deposits. Clinicopathological analysis revealed no significant differences in the extent of muscular amyloid deposition between the two groups. Nevertheless, patients in Group 1 displayed more pronounced neurogenic atrophy on skeletal muscle biopsies.
Conclusions
Our study indicates that amyloid deposition in skeletal muscle is commonly observed but rarely causes symptomatic myopathy in systemic amyloidosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Institute of Neuromuscular and Neurodegenerative Diseases, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
- Department of Neurology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
- National Key Laboratory for Innovation and Transformation of Luobing Theory, The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and C…
ORCID-Profile: Wei Li
Förderung
- National Nature Science Foundation of China
- National Natural Science Foundation of China
Zitieren
APA
Xu, J., Zhou, X., Wang, Y., Liu, W., Shan, Y., Zhang, D., Lv, H., Zhao, D., Dai, T., Zhao, Y., Li, W., Liu, F., & Yan, C. (2024). Skeletal muscle involvement in systemic amyloidosis is often overlooked. Neuropathology and Applied Neurobiology. https://doi.org/10.1111/nan.12996
Vancouver
Xu J, Zhou X, Wang Y, Liu W, Shan Y, Zhang D, et al. Skeletal muscle involvement in systemic amyloidosis is often overlooked. Neuropathology and Applied Neurobiology. 2024. doi:10.1111/nan.12996
BibTeX
@article{Xu2024,
author = {Xu, Jingwen and Zhou, Xiaoyu and Wang, Yingxin and Liu, Wenzhu and Shan, Yi and Zhang, Dong and Lv, Huixia and Zhao, Dandan and Dai, Tingjun and Zhao, Yuying and Li, Wei and Liu, Fuchen and Yan, Chuanzhu},
title = {Skeletal muscle involvement in systemic amyloidosis is often overlooked},
journal = {Neuropathology and Applied Neurobiology},
year = {2024},
doi = {10.1111/nan.12996}
}
EUVIMED